HuFriedyGroup Clinical Navigator

Targeted Healing Approach for Teeth and Implants

Interactive clinical decision pathway

e78d43d
NoNoYesYesContinueContinueContinueContinueContinueContinueContinueContinueNo, persistingNo, persistingAccess flapAccess flapResectiveResectiveReconstructiveReconstructiveStartPrimordialDiagnosisHealthyMucositisPeri-implantitisSPICMucositis txNon-SurgRe-evalSurgeryAccess flapResectiveReconstr

Re-evaluation: 6–12 Months

Have treatment endpoints been met?

GPUpskilled GP
Hero illustration · Re-evaluation: 6–12 Months

Evaluate at 6–12 weeks. End points: PD ≤5 mm, no BOP at >1 point, no suppuration.

Evidence Guidelines & evidence
  • EFP S3 R7.3
    End points: residual probing depths ≤5 mm with no BOP at more than one point and no suppuration. Evaluate 6–12 weeks after therapy. If not achieved, consider additional treatment.
1

Re-assessment at 6–12 weeks

Probing depth re-assessment at every site. BOP at each site. Suppuration check. Radiographic comparison to baseline. End points (R7.3): PD ≤5 mm, no BOP at >1 point, no suppuration.

Illustration · Step 1
Select

Premium

Your decision